Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04738643 · ClinicalTrials.gov registry record · NA
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke
A NA study of Cancer and Smoking, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 685
- Enrollment target
- 2
- Study locations
NCT04738643 is a NA study of Cancer and Smoking that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 685 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04738643, a NA study of Cancer and Smoking, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 685 participants
- Enrollment target
- 2
- Study locations
Study Summary
The research objective is to identify a simple, pragmatic, innovative way of enhancing Tobacco Use Treatment (TUT) rates within oncology. To investigate this possibility, the investigators propose methods that will allow them to: 1) evaluate the impact of standing orders to initiate a varenicline management protocol within outpatient cancer treatment workflow, 2) assess the potential for an EHR-based intervention to affect patient TUT behaviors, and 3) identify important facilitators and barriers that impact effectiveness of the intervention. The investigators will assess whether including a standing order for prescription and management of varenicline (TUT Service+VM) within the workflow for cancer patients identified as current smokers will significantly increase TUT engagement rates compared to current standard of care (TUT Service alone). The investigators hypothesize that observed treatment engagement rates will be higher among clinicians exposed to TUT Service+VM than observed in clinicians exposed to TUT Service alone.
Conditions Studied
Interventions
- OTHER Tobacco Use Treatment Service and Varenicline Management
Study Locations (2)
Pennsylvania
- Penn Presbyterian Medical Center - Philadelphia
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 685 participants |
| Start Date | 2022-06-28 |
| Est. Completion | 2024-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04738643
The ClinicalTrials.gov registry entry for NCT04738643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 685 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (80% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tobacco Use Treatment Service and Varenicline Management is the first listed.
NCT04738643 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04738643 about?
NCT04738643 is a clinical study titled "Improving Tobacco Treatment Rates for Cancer Patients Who Smoke". The research objective is to identify a simple, pragmatic, innovative way of enhancing Tobacco Use Treatment (TUT) rates within oncology. To investigate this possibility, the investigators propose methods that will allow them to: 1) evaluate the impact of standing orders to initiate a varenicline ma...
What is the current status of trial NCT04738643?
This trial is currently completed. It is a NA study. The enrollment target is 685 participants. The study started on 2022-06-28. Estimated completion is 2024-01-24.
What conditions does trial NCT04738643 study?
This clinical trial studies the following conditions: Cancer, Smoking, Tobacco Use, Nicotine Dependence.
What interventions are being tested in trial NCT04738643?
The interventions under investigation include: Tobacco Use Treatment Service and Varenicline Management (OTHER).
Who is sponsoring clinical trial NCT04738643?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04738643 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.